mRNA Vaccines and Therapeutics Market Report

Global and China mRNA Vaccines and Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 11, 2022
  • PAGES：229
  • REPORT CODE：GMM1363732
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

    mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Ethris, SB-FIX, SB-318, SB-913 of Tiba Biotechnology. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.

    This report elaborates on the current development of the mRNA Vaccines and Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Translate Bio

    • Sangamo Therapeutics

    • Argos Therapeutics

    • In-Cell-Art

    • Tiba Biotechnology

    • Ethris

    • CureVac

    • Moderna Therapeutics

    • BioNTech

    • eTheRNA

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    Application:

    • Infectious Disease

    • Cancer

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 mRNA Vaccines and Therapeutics Industry Overview

      • 1.1.1 mRNA Vaccines and Therapeutics Market Scope and Market Segments

      • 1.1.2 mRNA Vaccines and Therapeutics Industry Characteristics

      • 1.1.3 Global and China mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China mRNA Vaccines and Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Standardization Of Cancer Treatment MRNA Vaccine

      • 1.2.2 Individualized Cancer Treatment MRNA Vaccine

      • 1.2.3 Infectious Disease Treatment MRNA Vaccine

      • 1.2.4 Infection Prevention MRNA Vaccine

    • 1.3 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Infectious Disease

      • 1.3.2 Cancer

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global mRNA Vaccines and Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global mRNA Vaccines and Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China mRNA Vaccines and Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China mRNA Vaccines and Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global mRNA Vaccines and Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 mRNA Vaccines and Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 mRNA Vaccines and Therapeutics Industry PEST Analysis

    • 2.3 mRNA Vaccines and Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 mRNA Vaccines and Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on mRNA Vaccines and Therapeutics Industry

    Chapter 3 Global and China mRNA Vaccines and Therapeutics Market, by Manufacturer

    • 3.1 Global and China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China mRNA Vaccines and Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China mRNA Vaccines and Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China mRNA Vaccines and Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China mRNA Vaccines and Therapeutics Market Top 3 Players

    Chapter 4 Global and China mRNA Vaccines and Therapeutics Market, by Type (2017-2028)

    • 4.1 mRNA Vaccines and Therapeutics Market Trend, by Type

    • 4.2 Global mRNA Vaccines and Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global mRNA Vaccines and Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global mRNA Vaccines and Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global mRNA Vaccines and Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China mRNA Vaccines and Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China mRNA Vaccines and Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China mRNA Vaccines and Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China mRNA Vaccines and Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China mRNA Vaccines and Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global mRNA Vaccines and Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global mRNA Vaccines and Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China mRNA Vaccines and Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China mRNA Vaccines and Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global mRNA Vaccines and Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America mRNA Vaccines and Therapeutics Market Analysis

    • 7.1 North America mRNA Vaccines and Therapeutics Market, by Type

    • 7.2 North America mRNA Vaccines and Therapeutics Market, by Application

    • 7.3 North America mRNA Vaccines and Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe mRNA Vaccines and Therapeutics Market Analysis

    • 8.1 Europe mRNA Vaccines and Therapeutics Market, by Type

    • 8.2 Europe mRNA Vaccines and Therapeutics Market, by Application

    • 8.3 Europe mRNA Vaccines and Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC mRNA Vaccines and Therapeutics Market Analysis

    • 9.1 APAC mRNA Vaccines and Therapeutics Market, by Type

    • 9.2 APAC mRNA Vaccines and Therapeutics Market, by Application

    • 9.3 APAC mRNA Vaccines and Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China mRNA Vaccines and Therapeutics Company Profiles

      • 11.1 Translate Bio

        • 11.1.1 Translate Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Translate Bio mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Translate Bio mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sangamo Therapeutics

        • 11.2.1 Sangamo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Sangamo Therapeutics mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Argos Therapeutics

        • 11.3.1 Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Argos Therapeutics mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Argos Therapeutics mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 In-Cell-Art

        • 11.4.1 In-Cell-Art Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 In-Cell-Art mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.4.3 In-Cell-Art mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Tiba Biotechnology

        • 11.5.1 Tiba Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Tiba Biotechnology mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Ethris

        • 11.6.1 Ethris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Ethris mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Ethris mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 CureVac

        • 11.7.1 CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 CureVac mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.7.3 CureVac mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Moderna Therapeutics

        • 11.8.1 Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Moderna Therapeutics mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 BioNTech

        • 11.9.1 BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 BioNTech mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.9.3 BioNTech mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 eTheRNA

        • 11.10.1 eTheRNA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 eTheRNA mRNA Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.10.3 eTheRNA mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 mRNA Vaccines and Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 mRNA Vaccines and Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 mRNA Vaccines and Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Cancer (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Other (2017-2028)

    • Figure North America mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China mRNA Vaccines and Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China mRNA Vaccines and Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China mRNA Vaccines and Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China mRNA Vaccines and Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China mRNA Vaccines and Therapeutics Market Share, by Manufacturer in 2022

    • Table Global mRNA Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global mRNA Vaccines and Therapeutics Sales Value, by Type (2017-2028)

    • Table Global mRNA Vaccines and Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Price Trend, by Type (2017-2028)

    • Table China mRNA Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table China mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China mRNA Vaccines and Therapeutics Sales Value, by Type (2017-2028)

    • Table China mRNA Vaccines and Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Price Trend, by Type (2017-2028)

    • Table Global mRNA Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global mRNA Vaccines and Therapeutics Sales Value, by Application (2017-2028)

    • Table Global mRNA Vaccines and Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global mRNA Vaccines and Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China mRNA Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table China mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China mRNA Vaccines and Therapeutics Sales Value, by Application (2017-2028)

    • Table China mRNA Vaccines and Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America mRNA Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America mRNA Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe mRNA Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe mRNA Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC mRNA Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC mRNA Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina mRNA Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina mRNA Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Translate Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Translate Bio Product Profiles, Application and Specification

    • Table Translate Bio mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sangamo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sangamo Therapeutics Product Profiles, Application and Specification

    • Table Sangamo Therapeutics mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Argos Therapeutics Product Profiles, Application and Specification

    • Table Argos Therapeutics mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table In-Cell-Art Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table In-Cell-Art Product Profiles, Application and Specification

    • Table In-Cell-Art mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tiba Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tiba Biotechnology Product Profiles, Application and Specification

    • Table Tiba Biotechnology mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ethris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ethris Product Profiles, Application and Specification

    • Table Ethris mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CureVac Product Profiles, Application and Specification

    • Table CureVac mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Moderna Therapeutics Product Profiles, Application and Specification

    • Table Moderna Therapeutics mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioNTech Product Profiles, Application and Specification

    • Table BioNTech mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table eTheRNA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table eTheRNA Product Profiles, Application and Specification

    • Table eTheRNA mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US